Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Randomized Phase III Trial Comparing Hypofractionated Versus Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiation in Terms of Lymphedema Occurrence

NCT03127995 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT03127995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03127995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Randomized Phase III Trial Comparing Hypofractionated Versus Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiation in Terms of Lymphedema Occurrence
Lead sponsor
UNICANCER
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 30, 2016
Completion date
September 30, 2030
Enrollment
1,265 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female